<DOC>
	<DOCNO>NCT00236171</DOCNO>
	<brief_summary>The purpose study evaluate efficacy topical therapy Protopic Advantan well combination placebo Psoriasis Plaque Test</brief_summary>
	<brief_title>Evaluation Topical Antipsoriatics Psoriasis Plaque Test</brief_title>
	<detailed_description>daily psoriasis plaque test two week optical coherence tomography ( OCT ) 20-MHz-ultrasound day 0 day 11 , 10 day post end treatment 20 day post end treatment</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Patients older 18 Years Negative urine pregnancy test Written inform consent Good compliance Patients le 18 year Pregnant patient Patients renal insufficiency , liver diseases Patients receive systemic antipsoriatic treatment UV treatment le 4 week prior study Patients use topical antipsoriatics within two week prior study Immunosuppressed Patients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>topical therapy</keyword>
	<keyword>Psoriasis Plaque Test</keyword>
</DOC>